NHS England agrees deal for gene therapy for spinal muscular atrophy
A vaccine against malaria: five minutes with . . . Richard Bucala
8 March 2021Why you shouldn’t neglect eye care during the pandemic
8 March 2021NHS England agrees deal for gene therapy for spinal muscular atrophy
NHS England has agreed a deal to ensure that Zolgensma (onasemnogene abeparvovec), a one-off gene therapy medicine, will be made available for patients with spinal muscular atrophy.The drug, labelled…
